BioTech IQ

67 Folgen

1. #26 How do you know the right path of development? Mike Rea, CEO - IDEA Pharma

   Vom: 1.9.2021
2. #25 Potential Tumor Immunity? Grant Yonehiro, CBO - Bolt BioTherapeutics

   Vom: 11.8.2021
3. #24 A fellowship program for biotech founders? Meet: Brazen Bio

   Vom: 16.7.2021
4. #23 Targeting treatment related toxicities - Michael McCullar - CEO OnQuality Pharmaceuticals

   Vom: 9.7.2021
5. #22 Regulatory Affairs Strategy w/Dr. Jethro Ekuta - VP, Global RA

   Vom: 25.6.2021
6. #21 Research and Development Tax Credits

   Vom: 11.6.2021
7. #20 Can longevity really be extended? Eric Leire, MD - CEO GenFlow Biosciences

   Vom: 7.5.2021
8. #19 Bing Du, MD - Senior Director, Global Patient Safety - BeiGene, Ltd.

   Vom: 8.4.2021
9. #18 Ed Tucker, MD, MBA - Chief Medical Officer - Mirum Pharmaceuticals

   Vom: 18.3.2021
10. #17 Patti Engel - CEO of Engage Health Discusses Rare Disease

    Vom: 24.2.2021
11. #16 Amy Baxter, MD, FAAP, FACEP - Founder and CEO of Pain Care Labs

    Vom: 14.2.2021
12. #15 David Chonzi, MD - Global Head of PVE with Instil Bio

    Vom: 30.1.2021
13. #14 Juliana Oliveira, MD, PhD - VP Clinical Development, Viking Therapeutics

    Vom: 21.1.2021
14. #13 Jo Bhakdi - Founder and CEO of Quantgene

    Vom: 5.12.2020
15. #12 James Kirwin - COO SFA Therapeutics and Experienced Clinical Operations Expert

    Vom: 23.11.2020
16. #11 Michelle McGuinness - Pharmaceutical Compliance Partners

    Vom: 14.11.2020
17. #10 Aleisha Dobbins, PhD, MBA - QA and GCP Consultant

    Vom: 7.11.2020
18. #9 Salah Kivlighn, PHD - The Kivlighn Group

    Vom: 31.10.2020
19. #8 Rolf Linke, MD - Chief Medical Officer - SFJ Pharmaceuticals

    Vom: 23.10.2020
20. #7 Gwen Nichols, MD - Chief Medical Officer - The Leukemia & Lymphoma Society

    Vom: 16.10.2020